← Open Payments lookup

RUEL MARIANO: Open Payments

NPI 1114481785 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,248 in 25 payments from 10 companies in 2025. Trend: 2023 $947 · 2024 $707 · 2025 $1,248

Food & beverage: $1,248
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$219
ABBVIE INC.6$203
E.R. Squibb & Sons, L.L.C.6$172
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$149
Indivior Inc.1$125
Bayer Healthcare Pharmaceuticals Inc.1$122
Novo Nordisk Inc1$119
Collegium Pharmaceutical, Inc.4$77
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$36
Forte Bio-Pharma LLC1$26

Products named: QULIPTA, COBENFY, CAPLYTA, SUBLOCADE, Kerendia, FARXIGA, Ozempic, BREZTRI.

Industry payments across NV — which companies pay providers there.